Vanguard Group Inc Abbott Laboratories Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Vanguard Group Inc holds 165,301,921 shares of ABT stock, worth $17.2 Billion. This represents 0.38% of its overall portfolio holdings.
Number of Shares
165,301,921
Previous 156,467,081
5.65%
Holding current value
$17.2 Billion
Previous $17.2 Billion
9.09%
% of portfolio
0.38%
Previous 0.38%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,122Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Black Rock Inc. New York, NY133MShares$13.9 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.74 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.78 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.3 Billion1.65% of portfolio
-
Morgan Stanley New York, NY36MShares$3.75 Billion0.33% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...